Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ILMN vs GSK✓SelectedUSD · GSKILMN vs GSK performance historyLatest closeAs of+3.65%11/18
Stock and ETF performance explorer

ILMN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+72.2%
GSK return
+7.0%
Excess return
+65.2%
Maximum drawdown
-32.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.7%-1.3%+5.0%+3.7%
7D-1.4%-3.1%+1.8%-1.4%
30D-20.0%-0.9%-19.2%-20.0%
3M+11.5%-4.2%+15.7%+12.1%
6M+48.4%-1.6%+50.0%+47.9%
YTD+60.1%+2.6%+57.5%+57.9%
1Y+72.2%+6.2%+66.0%+67.4%
All+72.2%+7.0%+65.2%+67.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling